Congress Trades

Coverage gap. Senate eFD: the last 15 checks failed; last successful check Oct 23. New filings from this source are not coming in. Newest Senate eFD filing on this site: 2026-10-21.

Source status

NBIXNeurocrine Biosciences, Inc.

Healthcare · Drug Manufacturers - Specialty & GenericNasdaqStockMkt cap $15.9B
Disclosed trades
16
0 in 30d · 0 in 90d
Politicians
4
Last trade Jun 17, 2025
Buys
11
$369K at range midpoints
Sells
5
$174K at range midpoints

Closing price · 365 days

Nov 7, 2025 – Nov 6, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

3 hold it now Estimated
Politicians who traded NBIX
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last tradeEst. position Estimated
RMichael T. McCaulHouse · TX-101082$345K$150KJun 24, 2021$498.1K
DGilbert Ray Cisneros, Jr.House · CA-31211$8K$8KDec 21, 2020$13.1K
RLisa C. McClainHouse · MI-09211$8K$8KJun 17, 2025$60
DRo KhannaHouse · CA-17211$8K$8KFeb 10, 2023—

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountvs S&P EstimatedTradedFiledSource
RLisa C. McClainNBIXNeurocrine Biosciences, Inc. - Common Stock (NBIX)PartialSpouse$1,001 - $15,000-11.1%Jun 17, 2025Aug 13, 202557dFiling
RLisa C. McClainNBIXNeurocrine Biosciences, Inc. - Common Stock (NBIX)BuySpouse$1,001 - $15,000+11.1%Jun 11, 2025Aug 13, 202563dFiling
DRo KhannaNBIXNEUROCRINE BIOSCIENCES, INC., CMNSellSpouse$1,001 - $15,000+19.2%Feb 10, 2023Mar 3, 202321dFilingOCR
DRo KhannaNBIXNEUROCRINE BIOSCIENCES.INC.CMNBuySpouse$1,001 - $15,000-55.6%Dec 6, 2022Jan 6, 202331dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuyReviewUnknown$15,001 - $50,000+2.8%Jun 24, 2021Jul 16, 202122dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuyReviewUnknown$15,001 - $50,000+2.8%Jun 24, 2021Jul 16, 202122dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuyReviewUnknown$15,001 - $50,000-3.5%Mar 9, 2021Apr 19, 202141dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuyReviewUnknown$15,001 - $50,000-3.5%Mar 8, 2021Apr 19, 202142dFilingOCR
DGilbert Ray Cisneros, Jr.NBIXNeurocrine biosciences, Inc. (NbIX)BuySelf$1,001 - $15,000-44.9%Dec 21, 2020Jan 11, 202121dFiling
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuyDependent$50,001 - $100,000-33.8%Nov 12, 2020Jan 7, 202156dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuySpouse$50,001 - $100,000-33.8%Nov 12, 2020Jan 7, 202156dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCSellDependent$50,001 - $100,000+29.7%Oct 1, 2020Nov 30, 202060dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCSellSpouse$50,001 - $100,000+29.7%Oct 1, 2020Nov 30, 202060dFilingOCR
DGilbert Ray Cisneros, Jr.NBIXNeurocrine biosciences, Inc. (NbIX)PartialSelf$1,001 - $15,000+72.5%Jul 21, 2020Aug 19, 202029dFiling
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuyDependent$15,001 - $50,000-99.6%Mar 2, 2020May 6, 202065dFilingOCR
RMichael T. McCaulNBIXNEUROCRINE BIOSCIENCES INCBuySpouse$15,001 - $50,000-99.6%Mar 2, 2020May 6, 202065dFilingOCR